https://www.selleckchem.com/products/cx-5461.html
PKG-dependent signaling on SGNs would represent an attractive therapeutic candidate for hearing impairment.Triple-negative breast cancer is a heterogeneous disease that still lacks specific therapeutic approaches. The identification of new biomarkers, predictive of the disease's aggressiveness and pharmacological response, is a challenge for a more tailored approach in the clinical management of patients. Nerve growth factor, initially identified as a key factor for neuronal survival and differentiation, turned out to be a multifaceted
Like
Comment
Share
